Paper Details

Paper Title

Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.

Paper Journal Title

Clin Cancer Res

Paper Citation Count

Paper Publication Year

2021

Bio Mention

Human Papillomavirus-unrelated Head and Neck Cancer

Mesh Descriptor

Paper Details

Column Actions

Datasets